Nutex Health (NASDAQ:NUTX) Shares Gap Up – Should You Buy?

Nutex Health Inc. (NASDAQ:NUTXGet Free Report)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $125.03, but opened at $132.91. Nutex Health shares last traded at $137.6940, with a volume of 14,474 shares traded.

Wall Street Analysts Forecast Growth

NUTX has been the subject of a number of recent analyst reports. Wall Street Zen raised Nutex Health from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Lake Street Capital initiated coverage on Nutex Health in a research report on Tuesday. They issued a “buy” rating and a $235.00 price objective for the company. Finally, Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Monday, May 4th. Two equities research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat.com, Nutex Health currently has an average rating of “Moderate Buy” and a consensus price target of $220.00.

Check Out Our Latest Research Report on Nutex Health

Nutex Health Price Performance

The company has a market cap of $912.22 million, a PE ratio of 10.25 and a beta of 0.26. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.12 and a current ratio of 3.14. The stock has a 50 day moving average of $115.63 and a 200-day moving average of $128.24.

Nutex Health (NASDAQ:NUTXGet Free Report) last issued its earnings results on Thursday, April 30th. The company reported $6.52 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53. The company had revenue of $216.49 million during the quarter, compared to analyst estimates of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.

Hedge Funds Weigh In On Nutex Health

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NUTX. Pertento Partners LLP purchased a new position in Nutex Health in the 3rd quarter worth $27,940,000. Topline Capital Management LLC raised its stake in Nutex Health by 80.0% in the 3rd quarter. Topline Capital Management LLC now owns 556,567 shares of the company’s stock worth $57,505,000 after acquiring an additional 247,436 shares during the last quarter. Millennium Management LLC raised its stake in Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company’s stock worth $9,650,000 after acquiring an additional 61,308 shares during the last quarter. Empowered Funds LLC purchased a new position in Nutex Health in the 1st quarter worth $3,084,000. Finally, SG Americas Securities LLC raised its stake in shares of Nutex Health by 3,232.6% during the 1st quarter. SG Americas Securities LLC now owns 30,360 shares of the company’s stock valued at $2,885,000 after buying an additional 29,449 shares during the last quarter. Hedge funds and other institutional investors own 5.32% of the company’s stock.

About Nutex Health

(Get Free Report)

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

Featured Stories

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.